FDA Approved: VIGAFYDE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for VIGAFYDE (vigabatrin) submitted by Upsher-Smith Laboratories, LLC. The action updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Infantile Spasms

Drugs mentioned

• VIGAFYDE (VIGABATRIN)

Snippet

SUPPL AP for VIGAFYDE (VIGABATRIN)